United Therapeutics (UTHR) Selling, General & Administrative (2009 - 2026)
United Therapeutics (UTHR) reported Selling, General & Administrative of $206.7 million for Q2 2026, down 2.7% from $212.5 million a year earlier but up 12.3% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, United Therapeutics' Selling, General & Administrative came in at $764 million, down 0.8% year-over-year; for FY2025, it came in at $755.8 million, up 6.5% from FY2024.
- Selling, General & Administrative has a four-year compound annual growth rate of 12.8% (FY2021 to FY2025).
- By year, Selling, General & Administrative came in at $709.7 million in FY2024 (+48.8%), $477.1 million in FY2023 (-1.0%), $482.1 million in FY2022 (+3.2%) and $467 million in FY2021.
- Five-year quarterly Selling, General & Administrative spans a low of $79 million in Q1 2022 and a high of $219.2 million in Q3 2024.
- Year over year, Selling, General & Administrative gained in six of the last eight quarters, with growth averaging 17.3%.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2024 (growth of 71.8%); the low point was Q4 2023 (a decline of 19.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $184.1 million (Q1 2026), $190.6 million (Q4 2025) and $182.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | United Therapeutics | 23.12 Bn | 12.61 Bn | 683.80 Mn | 206.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.70 Mn |
| Mar 31, 2026 | 184.10 Mn |
| Dec 31, 2025 | 190.60 Mn |
| Sep 30, 2025 | 182.60 Mn |
| Jun 30, 2025 | 212.50 Mn |
| Mar 31, 2025 | 170.10 Mn |
| Dec 31, 2024 | 168.50 Mn |
| Sep 30, 2024 | 219.20 Mn |
| Jun 30, 2024 | 177.60 Mn |
| Mar 31, 2024 | 144.40 Mn |
| Dec 31, 2023 | 132.20 Mn |
| Sep 30, 2023 | 127.60 Mn |
| Jun 30, 2023 | 130.00 Mn |
| Mar 31, 2023 | 87.30 Mn |
| Dec 31, 2022 | 163.20 Mn |
| Sep 30, 2022 | 98.40 Mn |
| Jun 30, 2022 | 141.50 Mn |
| Mar 31, 2022 | 79.00 Mn |
| Dec 31, 2021 | 127.90 Mn |
| Sep 30, 2021 | 109.10 Mn |
API Access
United Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();